TrianglePUBLICATIONS · 30197327
Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Cancer Res Ther
- Publication date
- 2018 Jul-Sep
- First author
- Gupta A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Gupta A
- type
- Author
- name
- Gokarn A
- type
- Author
- name
- Rajamanickam D
- type
- Author
- name
- Punatar S
- type
- Author
- name
- Thippeswamy R
- type
- Author
- name
- Mathew L
- type
- Author
- name
- Bagal B
- type
- Author
- name
- Kannan S
- type
- Author
- name
- Khattry N
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Gupta A
- type
- Author
- name
- Gokarn A
- type
- Author
- name
- Rajamanickam D
- type
- Author
- name
- Punatar S
- type
- Author
- name
- Thippeswamy R
- type
- Author
- name
- Mathew L
- type
- Author
- name
- Bagal B
- type
- Author
- name
- Kannan S
- type
- Author
- name
- Khattry N
- type
- Author
- bibliography ids
- nci-bib-4ce9161bfb6bcbde30e20293
- book metadata
- content sha256
- efb24a52668276116ef7dd17b07a484439d8050a00acae9918a2f88506eff3c5
- document type
- citation
- dois
- 10.4103/0973-1482.181183
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30197327
- immutable id
- pubmed:30197327@efb24a52668276116ef7dd17b07a484439d8050a00acae9918a2f88506eff3c5
- journal
- abbreviation
- J Cancer Res Ther
- issn electronic
- 1998-4138
- issn print
- Source null
- issue
- 5
- name
- Journal of cancer research and therapeutics
- nlm unique id
- 101249598
- pages
- 926-933
- volume
- 14
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30197327
- provenance
- batch id
- 438b2803888025c6cf56
- provider
- NCBI PubMed ESummary
- record sha256
- bfe15c4564e6ad5a0f40c65cd586c6f97dbeea9fa985f553ee7d454a6f1dd85f
- response sha256
- 0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
- retrieved at
- 2026-09-09T23:47:36.359220+00:00
- publication date
- display
- 2018 Jul-Sep
- precision
- range_or_season
- year
- 2018
- publication types
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors.
Preserved source evidence · Not medical advice